Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma Journal Article


Authors: Antonescu, C. R.; Le Loarer, F.; Mosquera, J. M.; Sboner, A.; Zhang, L.; Chen, C. L.; Chen, H. W.; Pathan, N.; Krausz, T.; Dickson, B. C.; Weinreb, I.; Rubin, M. A.; Hameed, M.; Fletcher, C. D. M.
Article Title: Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
Abstract: Conventional epithelioid hemangioendotheliomas (EHE) have a distinctive morphologic appearance and are characterized by a recurrent t(1;3) translocation, resulting in a WWTR1-CAMTA1 fusion gene. We have recently encountered a fusion-negative subset characterized by a somewhat different morphology, including focally well-formed vasoformative features, which was further investigated for recurrent genetic abnormalities. Based on a case showing strong transcription factor E3 (TFE3) immunoreactivity, fluorescence in situ hybridization (FISH) analysis for TFE3 gene rearrangement was applied to the index case as well as to nine additional cases, selected through negative WWTR1-CAMTA1 screening. A control group, including 18 epithelioid hemangiomas, nine pseudomyogenic HE, and three epithelioid angiosarcomas, was also tested. TFE3 gene rearrangement was identified in 10 patients, with equal gender distribution and a mean age of 30 years old. The lesions were located in somatic soft tissue in six cases, lung in three and one in bone. One case with available frozen tissue was tested by RNA sequencing and FusionSeq data analysis to detect novel fusions. A YAP1-TFE3 fusion was thus detected, which was further validated by FISH and reverse transcription polymerase chain reaction (RT-PCR). YAP1 gene rearrangements were then confirmed in seven of the remaining nine TFE3-rearranged EHEs by FISH. No TFE3 structural abnormalities were detected in any of the controls. The TFE3-rearranged EHEs showed similar morphologic features with at least focally, well-formed vascular channels, in addition to a variably solid architecture. All tumors expressed endothelial markers, as well as strong nuclear TFE3. In summary, we are reporting a novel subset of EHE occurring in young adults, showing a distinct phenotype and YAP1-TFE3 fusions. © 2013 Wiley Periodicals, Inc.
Keywords: adolescent; adult; clinical article; controlled study; protein expression; middle aged; unclassified drug; cancer recurrence; bone metastasis; lymph node metastasis; genetic analysis; phenotype; in situ hybridization, fluorescence; reverse transcription polymerase chain reaction; protein; transcription factor; angiosarcoma; immunoreactivity; kidney neoplasms; lung tumor; liver metastasis; fluorescence in situ hybridization; gene rearrangement; lymphoma; fusion gene; oncogene proteins, fusion; adaptor proteins, signal transducing; phosphoproteins; base sequence; translocation, genetic; inguinal lymph node; sequence analysis, rna; soft tissue tumor; rna sequence; soft tissue metastasis; hemangioendothelioma; hemangioendothelioma, epithelioid; basic helix-loop-helix leucine zipper transcription factors; epithelioid hemangioendothelioma; protein yap1; transcription factor e3
Journal Title: Genes Chromosomes and Cancer
Volume: 52
Issue: 8
ISSN: 1045-2257
Publisher: Wiley Periodicals, Inc  
Date Published: 2013-08-01
Start Page: 775
End Page: 784
Language: English
DOI: 10.1002/gcc.22073
PROVIDER: scopus
PUBMED: 23737213
PMCID: PMC4089994
DOI/URL:
Notes: --- - "Export Date: 1 July 2013" - "CODEN: GCCAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Meera Hameed
    282 Hameed
  2. Cristina R Antonescu
    897 Antonescu
  3. Lei Zhang
    194 Zhang
  4. Chun Liang Chen
    35 Chen